Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Chen, Jian Jun ^a   Liu, Zhao ^a   Fan, Song Hua ^a   Yang, De Yu ^a   Zheng, Peng ^a   Shao, Wei Hua ^a   Qi, Zhi Guo ^a   Xu, Xue Jiao ^a   Li, Qi ^a   Mu, Jun ^a   Yang, Yong Tao ^a   Xie, Peng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AREA UNDER THE CURVE; BIPOLAR DISORDER; CASE CONTROL STUDY; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; MALE; MASS FRAGMENTOGRAPHY; METABOLOME; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; STATISTICS AND NUMERICAL DATA; URINE;

ADULT; AREA UNDER CURVE; BIOLOGICAL MARKERS; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DISCRIMINANT ANALYSIS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METABOLOME; METABOLOMICS; ROC CURVE;

EID: 84905187302     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05855     Document Type: Article

References (41)

1. Young, A. H. More good news about the magic ion: lithium may prevent dementia. Br J Psychiatry. 198, 336-7 (2011)
2. Merikangas, K. R. et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. ARCH GEN PSYCHIAT. 68, 241 (2011)
3. Müller-Oerlinghausen, B., Berghöfer, A.&Bauer, M. Bipolar disorder. Lancet 359, 241-7 (2002)
4. Oquendo, M., Currier, D. &Mann, J. Prospective studies of suicidal behavior in major depressive and bipolar disorders: What is the evidence for predictive risk factors? ACTA PSYCHIAT SCAND 114, 151-158 (2006)
5. Kaddurah-Daouk, R., Kristal, B. S.&Weinshilboum, R.M.Metabolomics: a global biochemical approach to drug response and disease. ANNU REV PHARMACOL 48, 653-83 (2008)
6. Villas-Boas, S. G. Metabolome Analysis, An Introduction. (Wiley, New Jersey, 2007)
7. Weckwerth, W. Metabolomics: Methods and Procedures. (Humana Press, New Jersey, 2007)
8. Kristal, B. S. Metabolomics: concept and potential neuroscience application. In Handbook of Neurochemistry and Molecular Neurobiology: Brain Energetics. Integration of Molecular and Cellular Processes. (Springer, New York, 2007)
9. Nicholson, J. K. &Lindon, J. C. Systems biology: metabonomics. Nature 455, 1054-1056 (2008)
10. Jung, J. Y. et al. 1H-NMR-Based Metabolomics Study of Cerebral Infarction. Stroke 42, 1282-8 (2011)
11. Noga, M. J. et al. Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis. Metabolomics 8, 253-263 (2012)
12. Yang, J. et al. Potential metabolite markers of schizophrenia. Mol Psychiatry. 18, 67-78 (2011)
13. Yap, I. K. et al. Nicholson. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J PROTEOME RES. 9, 2996-3004 (2010)
14. Zheng, P. et al. Identification and validation of urinary metabolite biomarkers for major depressive disorder. Mol Cell Proteomics. 12, 207-14 (2013)
15. Zheng, P. et al. A novel urinary metabolite signature for diagnosing major depressive disorder. J Proteome Res. 12, 5904-11 (2013)
16. Zheng, P. et al. Plasma metabonomics as a novel diagnostic approach for major depressive disorder. J Proteome Res. 11, 1741-8 (2012)
17. Lan,M. et al.Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. MOL PSYCHIATR. 14, 269-279 (2008)
18. Sussulini, A. et al.Metabolic profiling of human blood serum from treated patients with bipolar disorder employing 1H NMR spectroscopy and chemometrics. ANAL CHEM 81, 9755-63(2009)
19. Zheng, P. et al. Novel urinary biomarkers for diagnosing bipolar disorder. Metabolomics. 9, 800-808 (2013)
20. Xu, X. J. et al. 2, 4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder. Mol Biosyst. 10, 813-9 (2014)
21. Williams, R. et al. A multi-Analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats. Mol Biosyst. 2, 174-83 (2006)
22. Bouatra, S. et al. The human urine metabolome. PLoS One 8, e73076 (2013)
23. Law, W. S. et al. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/ mass spectrometry and H-1 NMR spectroscopy. Rapid Commun Mass Spectrom 22, 2436-2446 (2008)
24. Li, Y. et al.Metabonomics study of essential hypertension and its chinese medicine subtypes by using gas chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy. Evid Based Complement Alternat Med. 2013, 625906 (2013)
25. Andreazza, A. C. et al. Oxidative stress markers in bipolar disorder: a metaanalysis. J AFFECT DISORDERS. 111, 135-144 (2008)
26. Löffler, M., Fairbanks, L. D., Zameitat, E., Marinaki, A. M. &Simmonds, H. A. Pyrimidine pathways in health and disease. Trends Mol Med. 11, 430-7 (2005)
27. Xia, J. G., Mandal, R., Sinelnikov, I. V., Broadhurst, D. &Wishart, D. S. MetaboAnalyst 2.0-A comprehensive server for metabolomic data analysis. NUCLEIC ACIDS RES. 40, W127-33 (2012)
28. Micheli, V. et al. Neurological disorders of purine and pyrimidine metabolism. Curr Top Med Chem. 11, 923-47 (2011)
29. Chu, T. T., Liu, Y. &Kemether, E. Thalamic transcriptome screening in three psychiatric states. J Hum Genet. 54, 665-75 (2009)
30. Wu, F. S., Gibbs, T. T. &Farb, D. H. Dual activation of GABAA and glycine receptors by beta-Alanine: inverse modulation by progesterone and 5 alphapregnan- 3 alpha-ol-20-one. Eur J Pharmacol. 246, 239-46 (1993)
31. Fatemi, S. H., Folsom, T. D., Rooney, R. J. &Thuras, P. D. Expression of GABAA a2-, b1- and e-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder. Transl Psychiatry. 3, e303 (2013)
32. Zarate, C. A., Singh, J.&Manji, H. K. (2006) Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder.Biol Psychiatry. 59, 1006-1020 (2006)
33. Micheel, C. Evolution of Translational omics: Lessons Learned and the Path Forward (Institute of Medicine Consensus Report) (National Academies Press, Washington, 2012)
34. Beckwith-Hall, B. et al. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. CHEM RES TOXICOL. 11, 260-272 (1998)
35. Shao, W. H. et al. Metabolomic identification of molecular changes associated with stress resilience in the chronic mild stress rat model of depression. Metabolomics. 9, 433-443 (2012)
36. Roubaud-Baudron, C., Krolak-Salmon, P., Quadrio, I., Mégraud, F. &Salles, N. Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results. Neurobiol Aging. 33, 1009.e11-9 (2012)
37. Bylesj, M. et al. OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J Chemom. 20, 341-351 (2006)
38. Mahadevan, S., Shah, S. L., Marrie, T. J. &Slupsky, C.M. Analysis of metabolomic data using support vector machines. Anal Chem. 80, 7562-7570 (2008)
39. Cloarec, O. et al. Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. Anal Chem. 77, 517-526 (2005)
40. Qi, Y. et al. Urinary metabolite markers of precocious puberty. Mol Cell Proteomics. 11, M111.011072 (2012)
41. Oikonomopoulou, K. et al. Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel. Br J Cancer. 99, 1103-1113 (2008)